Non classé
Biomarkers and their Role in the Diagnosis and Treatment of Cholangiocarcinoma (CCA)
Researchers in Italy have written a helpful and very detailed review of biomarkers specific to iCCA. Biomarkers are measurable medical signs that c...
COR2ED’s New Resources on Advanced HCC
COR2ED is an independent medical education company that develops impactful educational programmes within specific therapeutic areas. They have rece...
WECAN Evidence-Based Advocacy Workshop
From 17-19 January, Lāsma Nikolaisone, a patient advocate from “Onkoalianse”, a member organisation of Digestive Cancers Europe in Lat...
Celebrating a Lifetime of Achievement: Dr Eric Van Cutsem Honoured as Professor Emeritus
Dr Eric Van Cutsem, world-renowned Professor of Clinical Digestive Oncology and co-founder of Digestive Cancers Europe, was lauded as Professor Eme...
Educational Booklets For Togas Pilot Studies Participants Are Now Available
Crafted with input from both patients and field experts, these booklets will undergo translation into national languages before distribution among ...
DiCE Supports MOs Training Opportunity
As an integral part of our commitment to patient care, we are pleased to inform you that DiCE will award two grants to DiCE Full members who are in...
Do You Dare to Think Differently about Cancer?
The Cancer Grand Challenges mission is “Uniting the World’s brightest minds against cancer’s toughest challenges”. Founded by CRUK (Cancer ...
Predictive Values of Blood-based RNA Signature for the FOLFIRINOX/FOLFOX Response in Advanced Pancreatic Cancer
Presently, no widely recognised or established biomarkers are specifically designed to predict the effectiveness of FOLFIRINOX/FOLFOX (chemotherape...
DIPLOMA Trial: Minimally Invasive Surgery is an Effective Treatment Option for Early-Stage Pancreatic Cancer
A notable study, DIPLOMA, led by Abu Hilal, M.D., Ph.D., of the Istituto Ospedaliero Fondazione Poliambulanza in Brescia, Italy, involved a large c...
ESMO Study Confirms Precision Oncology Remains Largely Inaccessible to European Cancer Patients
As a European umbrella organisation, DiCE is vocal in addressing the disparities associated with cancer patients’ access to precision medicin...
